CalciMedica Inc (CALC)
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data
📉 **NEGATIVE** • Medium confidence analysis (72%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (14%) **Content type:** Clinical